CPRX — CATALYST PHARMACEUTICALS INC

Ownership history in Scientech Research LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which Scientech Research LLC reported a position in CATALYST PHARMACEUTICALS INC (CPRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.18% (2025 Q3)
Avg. % of fund
0.12%
First filed
2024 Q3
Last filed
2025 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 26,423 +8,089 +44.1% 0.18% $521K $19.70
2025 Q2 ADDED 18,334 +1,554 +9.3% 0.10% $398K $21.70
2024 Q3 INITIATED 16,780 — — 0.07% $334K $19.88
% of Fund (quarterly)    CPRX price (monthly, adj. close)

Other funds also holding CPRX

As of 2025 Q4 — sorted by position size

TANAKA CAPITAL MANAGEMENT INC 3Y 7Y 4.87% GABLES CAPITAL MANAGEMENT INC. 3Y 7Y 4.19% JW Asset Management, LLC 3Y 7Y 2.95% Knott David M Jr 3Y 2.04% DEERFIELD MANAGEMENT COMPANY, L.P. 3Y 7Y 1.46% QSV Equity Investors LLC 1.24% Bridge City Capital, LLC 3Y 7Y 1.07% GLOBEFLEX CAPITAL L P 3Y 7Y 1.04% JUNCTURE WEALTH STRATEGIES, LLC 3Y 7Y 0.65% KENNEDY CAPITAL MANAGEMENT LLC 3Y 7Y 0.6%
← Back to Scientech Research LLC Holdings